Say Hello!
Don’t be shy.

   

Investment Tag

Image: Professors Alessio Ciulli and Sir Mike Ferguson Drugs development firm Amphista Therapeutics has unveiled a £38 million investment that will enhance its work to develop treatments for a range of diseases. The company is a spinout from Professor Alessio Ciulli’s labs at the University of Dundee’s School...

Glasgow-based IbisVision is ramping up the launch of its remote vision testing technology by bringing on additional staff in the UK and the US, its two main markets. Currently employing 10 people, the company has added two client-facing staff in the US where one of its...

(L-R) Sarah Hardy, Archangels; Carol Thomson, BDD | Photo credit: Jamie Williamson Backing to fund the further expansion of formulation and manufacturing capabilities underpinned by strategic senior appointments Innovative Scottish-based drug delivery company, Bio-Images Drug Delivery Limited (BDD), has positioned itself for rapid growth with a further round of...

A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment. BioCity Accelerator alumni, In4Derm Ltd, is an innovative drug discovery company developing the next generation of topical and oral therapies for widespread...

BioCity Glasgow based biotechnology company ILC Therapeutics (ILCT) today announced that it has secured significant investment from its first global investor Medical Incubator Japan (MIJ). The Scottish life sciences company, which has received international attention through its work exploring COVID-19 therapeutic treatments with the University...